Belite Bio Inc - ADR
BLTE
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.54B
Close$
$10.51
92.4% downside
Current Fair Value
92.4% downsideOvervalued by 92.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.54 Billion |
|---|---|
| Enterprise Value | $5.19 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.31 |
| Beta | -1.24 |
| Outstanding Shares | 39,868,666 |
Return
| Return on Equity | -11.72% |
|---|---|
| Return on Assets | -11.57% |
| Return on Invested Capital | -13.15% |
Valuation & Multiples
| P/E Ratio | -61.02 |
|---|---|
| PEG | -68.81 |
| Price to Sales | - |
| Price to Book Ratio | 7.27 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -51.15 |
| Enterprise Value to Net Income | -58 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 20, 2026
EPS Estimate
$-0.60
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 10, 2026
EPS Estimate
$-0.73
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 27.18%▲ 5.54% |
|---|---|
| Total Invested | $1.42B▲ 23.35% |
| Investors Holding | 75▲ 6.00% |
ESG Score
No data